These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4009614)

  • 21. Aminobenzoic acid diuretics. 1. 4-Halogeno-5-sulfamylmetanilic acid derivatives.
    Feit PW; Bruun H; Nielsen CK
    J Med Chem; 1970 Nov; 13(6):1071-5. PubMed ID: 5479843
    [No Abstract]   [Full Text] [Related]  

  • 22. Enhancement of nasal absorption of large molecular weight compounds by combination of mucolytic agent and nonionic surfactant.
    Matsuyama T; Morita T; Horikiri Y; Yamahara H; Yoshino H
    J Control Release; 2006 Jan; 110(2):347-352. PubMed ID: 16274829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rheological modifications of mucus in chronic bronchitic patients after treatment with stepronine-lysine salt.
    Braga PC; Bossi R; Allegra L
    Drugs Exp Clin Res; 1987; 13(11):707-10. PubMed ID: 3443046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of tasuldine and acetylcysteine on mucociliary clearance in patients with chronic airways obstruction.
    Dorow P; Weiss T; Felix R; Köhler M
    Arzneimittelforschung; 1986; 36(1):131-3. PubMed ID: 3954815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-acetylcysteine inhibits Na+ absorption across human nasal epithelial cells.
    Rochat T; Lacroix JS; Jornot L
    J Cell Physiol; 2004 Oct; 201(1):106-16. PubMed ID: 15281093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The evaluation of mucolytic drugs in chronic bronchitis.
    Shelley JH
    Br J Clin Pract; 1970 Dec; 24(12):533-8. PubMed ID: 4924491
    [No Abstract]   [Full Text] [Related]  

  • 27. N-acetylcysteine in patients with COPD exacerbations associated with increased sputum.
    Ayfer Aytemur Z; Baysak A; Ozdemir O; Köse T; Sayiner A
    Wien Klin Wochenschr; 2015 Apr; 127(7-8):256-61. PubMed ID: 25595117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A formulation for in situ lysis of mucin secreted in pseudomyxoma peritonei.
    Pillai K; Akhter J; Chua TC; Morris DL
    Int J Cancer; 2014 Jan; 134(2):478-86. PubMed ID: 23843173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic absorption enhancement of salmon calcitonin and reversible mucosal injury by applying a mucolytic agent and a non-ionic surfactant.
    Takatsuka S; Morita T; Koguchi A; Horikiri Y; Yamahara H; Yoshino H
    Int J Pharm; 2006 Jun; 316(1-2):124-30. PubMed ID: 16600541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [New 2,4-dibromo-6-(N-cyclohexyl-N-methyl)-aminomethylanilides of derivatives of cysteine and cystine with expectorant activity].
    Nardi D; Motta G; Tajana A; Catto A; Cazzulani P; Leonardi A
    Farmaco Sci; 1985 Feb; 40(2):108-19. PubMed ID: 3996580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multifaceted activity of N-acetyl-l-cysteine in chronic obstructive pulmonary disease.
    Calzetta L; Matera MG; Rogliani P; Cazzola M
    Expert Rev Respir Med; 2018 Aug; 12(8):693-708. PubMed ID: 29972340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The reduction in vitro in viscosity of mucoprotein solutions by a new mucolytic agent, N-acetyl-L-cysteine.
    SHEFFNER AL
    Ann N Y Acad Sci; 1963 Mar; 106():298-310. PubMed ID: 13977050
    [No Abstract]   [Full Text] [Related]  

  • 33. [On the mechanism of the mucolytic action of N-acetyl-L-cysteine].
    Galzigna L; Reggiani A
    Boll Soc Ital Biol Sper; 1965 Jan; 41(1):54-6. PubMed ID: 5875804
    [No Abstract]   [Full Text] [Related]  

  • 34. Nesosteine: a new mucoregulatory agent.
    Scuri R; Mondani P; Frova C; Fantini L
    Drugs Exp Clin Res; 1986; 12(8):663-70. PubMed ID: 3757762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of thiol derivatives on mixed mucus and blood clots in vitro.
    Risack LE; Vandevelde ME; Gobert JG
    Resuscitation; 1978; 6(1):9-20. PubMed ID: 97741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of mucolytic agents on the rheologic and transport properties of canine tracheal mucus.
    Martin R; Litt M; Marriott C
    Am Rev Respir Dis; 1980 Mar; 121(3):495-500. PubMed ID: 6968166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical applications of N-acetylcysteine.
    Kelly GS
    Altern Med Rev; 1998 Apr; 3(2):114-27. PubMed ID: 9577247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent advances of knowledge on the mechanism of action of drugs modifying the bronchial secretions.
    Morandini GC; Perduca M; Finiguerra M; De Martini S; Fraticelli G
    Int J Clin Pharmacol Res; 1986; 6(5):415-23. PubMed ID: 3781704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antifertility activity of N-protected glycine activated esters.
    Drew JH; Loeffler LJ; Hall IH
    J Pharm Sci; 1981 Jan; 70(1):60-3. PubMed ID: 7229931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A NEW MUCOLYTIC AGENT AS A THERAPEUTIC ADJUNCT IN NASAL SINUSITIS.
    KOMET H; SALCO AN
    Eye Ear Nose Throat Mon; 1965 Feb; 44():47-50. PubMed ID: 14273030
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.